
|Articles|March 1, 2002
Editorial: Asthma, on average
Until we learn to recognize susceptible infants and avert the immunologic response that results in asthma, we must improve the means by which we treat it.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease
2
New sunscreen ingredient clears FDA for the first time since the 1990s
3
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy
4
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis
5



